封面
市場調查報告書
商品編碼
1672727

組織和器官移植市場:按產品類型、按移植類型、按應用、按最終用戶、按地區

Tissue and Organ Transplantation Market, By Product Type, By Type of Transplant, By Application , By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 220 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球組織和器官移植市場規模估計為 187.5 億美元,預計到 2032 年將達到 356.5 億美元,2025 年至 2032 年的年複合成長率(CAGR)為 9.6%。

報告範圍 報告詳細資訊
基準年 2024 2025 年市場規模 187.5億美元
效能資料 2020-2024 預測期 2025-2032
預測期:2025 年至 2032 年複合年成長率 9.60% 2032 年金額預測 356.5億美元
圖。
組織與器官移植市場-IMG1

組織或器官移植是一種外科手術,將組織或器官從一個人轉移到另一個人,以修復、替換或增強接受者的器官或組織。組織和器官移植已成為世界上成長最快的醫學專業領域之一。組織和器官衰竭對人們的生活產生重大影響,但移植為全世界數百萬患者帶來了希望。由於文明病和道路事故導致的器官衰竭率不斷上升,推動了全球對組織和器官移植的需求。移植技術和預防移植排斥的免疫抑制療法的進步也推動了市場的成長。

市場動態

全球組織和器官移植市場的成長主要受到導致器官衰竭的慢性病和文明病盛行率上升的推動。此外,全球老化人口的不斷成長也推動了對替代組織和器官的需求。根據世界衛生組織估計,到2050年,65歲及以上人口預計將從2010年的5.24億增加到近15億。此外,移植技術的進步和更有效的免疫抑制劑的開發以防止器官排斥可能會為市場相關人員提供新的機會。然而,組織和器官移植程序的高成本以及合適器官的短缺可能會阻礙市場的成長。對器官販賣的倫理擔憂和對器官捐贈的宗教禁令可能會阻礙可移植器官的供應。

研究的主要特點

  • 本報告對全球組織和器官移植市場進行了詳細分析,並提供了預測期(2025-2032)的市場規模(十億美元)和年複合成長率(CAGR%),假設 2024 年為基準年。
  • 它還強調了各個領域的潛在商機並說明了該市場的有吸引力的投資提案矩陣。
  • 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
  • 全球組織和器官移植市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
  • 本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
  • 全球組織和器官移植市場報告針對該行業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
  • 相關人員可以透過全球組織和器官移植市場分析中使用的各種策略矩陣來促進決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • 一致的機會圖 (COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 影響分析
  • 市場趨勢
  • 監管情景
  • 收購和合作場景
  • 資金籌措和投資
  • PEST分析
  • 波特的分析

4. 全球組織與器官移植市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • 整體影響
  • 政府舉措
  • COVID-19 市場影響

5. 2020 年至 2032 年按產品類型分類的全球組織和器官移植市場(十億美元)

  • 介紹
  • 紙巾產品
  • 儲存解決方案
  • 免疫抑制劑

6. 2020 年至 2032 年按移植類型分類的全球組織和器官移植市場(十億美元)

  • 介紹
  • 活體移植
  • 屍體捐贈者移植
  • 自體移植
  • 異種移植
  • 同種異體移植

7. 2020 年至 2032 年全球組織與器官移植市場(按應用分類)(十億美元)

  • 介紹
  • 器官移植
  • 組織移植

8. 2020 年至 2032 年全球組織和器官移植市場(按最終用戶分類)(十億美元)

  • 介紹
  • 醫院
  • 移植中心
  • 組織函式庫
  • 其他

9. 2020 年至 2032 年全球組織與器官移植市場(按地區分類)(十億美元)

  • 介紹
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第10章 競爭格局

  • 公司簡介
    • BD(Becton, Dickinson and Company)
    • LabWare
    • Zimmer Biomet Holdings Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi
    • Medtronic PLC
    • Abbott
    • OrganOX Limited
    • Terumo Corporation
    • TransMedics Inc.
    • BioLife Solutions Inc.
    • Teva Pharmaceuticals
    • F. Hoffmann-La Roche Ltd.
    • Stryker Corporation
    • CryoLife Inc.
    • Abbvie, Inc.
    • Arthrex, Inc.

第 11 章 分析師建議

  • 興衰
  • 一致的機會地圖

第 12 章參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI4342

Global Tissue And Organ Transplantation Market is estimated to be valued at USD 18.75 Bn in 2025 and is expected to reach USD 35.65 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.6% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 18.75 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.60% 2032 Value Projection: USD 35.65 Bn
Figure. Tissue And Organ Transplantation Market Share (%), By Region 2025
Tissue and Organ Transplantation Market - IMG1

Tissue and organ transplantation refers to the surgical procedure of transferring tissues or organs from one person to another person to repair, replace or enhance the function of the recipient's organ or tissue. The transplantation of tissues and organs has become one of the most rapidly growing specialty areas of medicine in the world. Tissue and organ failure profoundly impact people's lives, however transplantation offers hope for millions of patients worldwide. Growing rates of organ failure due to lifestyle diseases and road accidents have boosted demand for tissue and organ transplantation globally. Advancements in transplantation techniques and immunosuppressive therapies that prevent rejection of transplants can also drive the market growth.

Market Dynamics:

Global tissue and organ transplantation market growth is primarily driven by rising prevalence of chronic diseases and lifestyle disorders resulting in organ failure. Growing geriatric population worldwide is also boosts demand for replacement tissues and organs. According to WHO, the number of people aged 65 years and older is projected to increase from 524 million in 2010 to nearly 1.5 billion in 2050. Furthermore, technological advancements in transplant procedures and development of more effective immunosuppressant drugs to prevent organ rejection can offer new opportunities for market players. However, high costs associated with tissue and organ transplantation surgeries and shortage of matching organs can hamper the market growth. Ethical concerns over organ trafficking and religious prohibitions on organ donations can hamper the supply of transplantable organs.

Key Features of the Study:

  • This report provides in-depth analysis of the global tissue and organ transplantation market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global tissue and organ transplantation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Zimmer Biomet, Medtronic PLC, Novartis AG, Stryker Corporation, 21st Century Medicine, BiolifeSolutions, CryoLife, Lonza Group
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global tissue and organ transplantation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tissue and organ transplantation market

Detailed Segmentation-

  • By Product Type
    • Tissue Products
    • Preservation Solution
    • Immunosuppressive Drugs
  • By Type of Transplant
    • Living Donor Transplant
    • Deceased Donor Transplant
    • Autograft Transplant
    • Xenograft Transplant
    • Allograft Transplant
  • By Application
    • Organ Transplantation
    • Tissue Transplantation
  • By End User
    • Hospital
    • Transplant Centers
    • Tissue Banks
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • BD (Becton, Dickinson and Company)
    • LabWare
    • Zimmer Biomet Holdings Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi
    • Medtronic PLC
    • Abbott
    • OrganOX Limited
    • Terumo Corporation
    • TransMedics Inc.
    • BioLife Solutions Inc.
    • Teva Pharmaceuticals
    • Hoffmann-La Roche Ltd.
    • Stryker Corporation
    • CryoLife Inc.
    • Abbvie, Inc
    • Arthrex, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Type of Transplant
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Tissue and Organ Transplantation Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Tissue and Organ Transplantation Market, By Product Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Tissue Products
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Preservation Solution
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Immunosuppressive Drugs
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Tissue and Organ Transplantation Market, By Type of Transplant, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Living Donor Transplant
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Deceased Donor Transplant
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Autograft Transplant
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Xenograft Transplant
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Allograft Transplant
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Tissue and Organ Transplantation Market, By Application, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Organ Transplantation
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Tissue Transplantation
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Tissue and Organ Transplantation Market, By End User, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Hospital
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Transplant Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Tissue Banks
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Tissue and Organ Transplantation Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Transplant, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Transplant, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Transplant, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Transplant, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Transplant, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Transplant, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Company Profiles
    • BD (Becton, Dickinson and Company)
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • LabWare
    • Zimmer Biomet Holdings Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi
    • Medtronic PLC
    • Abbott
    • OrganOX Limited
    • Terumo Corporation
    • TransMedics Inc.
    • BioLife Solutions Inc.
    • Teva Pharmaceuticals
    • F. Hoffmann-La Roche Ltd.
    • Stryker Corporation
    • CryoLife Inc.
    • Abbvie, Inc.
    • Arthrex, Inc.

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact